Targeting the Fas/FasL signaling pathway in cancer therapy.
about
Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer CellsEffect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Immunosuppressive MicroenvironmentThe new deal: a potential role for secreted vesicles in innate immunity and tumor progressionFASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjectsPreparation of a functional fluorescent human Fas ligand extracellular domain derivative using a three-dimensional structure guided site-specific fluorochrome conjugationA Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.Autophagy and cancer therapy.Characterization and Potential Antitumor Activity of Polysaccharide from Gracilariopsis lemaneiformis.Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.Site-specific chemical conjugation of human Fas ligand extracellular domain using trans-cyclooctene - methyltetrazine reactionsNanotechnology for the detection and kill of circulating tumor cells.Pigment epithelial-derived factor (PEDF)-triggered lung cancer cell apoptosis relies on p53 protein-driven Fas ligand (Fas-L) up-regulation and Fas protein cell surface translocation.Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.Clinical implications of Fas/Fas ligand expression in patients with esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy.Rab25 Small GTPase Mediates Secretion of Tumor Necrosis Factor Receptor Superfamily Member 11b (osteoprotegerin) Protecting Cancer Cells from Effects of TRAILAcellular fraction of ovarian cancer ascites induce apoptosis by activating JNK and inducing BRCA1, Fas and FasL expression in ovarian cancer cells.Enhancing production and cytotoxic activity of polymeric soluble FasL-based chimeric proteins by concomitant expression of soluble FasL.Modulation of SIV and HIV DNA vaccine immunity by Fas-FasL signalingTegillarca granosa extract Haishengsu induces apoptosis in human hepatocellular carcinoma cell line BEL-7402 via Fas-signaling pathways.NF-κB regulates caspase-4 expression and sensitizes neuroblastoma cells to Fas-induced apoptosis.KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.Matrix metalloproteinases as breast cancer drivers and therapeutic targets.Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-AnalysisUnphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance.Kidney tubular β-catenin signaling controls interstitial fibroblast fate via epithelial-mesenchymal communication.mTOR plays a critical role in p53-induced oxidative kidney cell injury in HIVAN.Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury.Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progressionImmunoglobulin E induces colon cancer cell apoptosis via enhancing cyp27b1 expression.Targeting cell death signaling in colorectal cancer: current strategies and future perspectives.Matrix Metalloproteinases-7 and Kidney Fibrosis.Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma.FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disordersFAS system deregulation in T-cell lymphoblastic lymphomaSignaling pathways in HPV-associated cancers and therapeutic implications.D4F alleviates macrophage-derived foam cell apoptosis by inhibiting the NF-κB-dependent Fas/FasL pathway.Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells.Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway.White Adipose Tissue Browning: A Double-edged Sword.Artesunate possesses anti-leukemia properties that can be enhanced by arsenic trioxide.
P2860
Q26752653-96B50AD0-0E2A-444B-B401-04BA685FA188Q26864045-1BA7D452-FAAE-48F2-A191-42C017FE962CQ28084891-7A3062C5-401E-40A3-8C0B-38974B4DA958Q28389021-66EC8D84-B42C-4BCB-B62F-83AC2B7D0266Q28831051-551FCA5A-B181-44D8-9E45-6CC9560D8D28Q30252954-B6E74870-8A88-44A3-B926-59D1EA0611AEQ33584607-49CC22F2-5BA7-4953-8F1B-AB265D59A740Q33612199-66F0FB05-2324-4F77-ABDC-55835AE13E7AQ33676412-791C4C66-3C7C-455E-A884-4216DA878B8FQ33868706-213FA0B5-E73A-4D38-BDBF-69EB0E5AC16BQ34241179-F83251A9-6279-4916-99B7-7B55D0385536Q34431110-82C64C51-FE3A-402D-9D12-3BC0630D0163Q34551169-3E8EDA8D-EA60-4873-80DD-7FB087B1D7DAQ34607210-A7C44B4F-0800-455D-B856-3DE2141B34CAQ34700466-AB722EDC-E621-47F8-BFC2-D3D181F1CDB3Q34781244-89F88900-9623-4DAC-9A0C-CDBC144C0A3DQ34977134-EF2745A3-E891-4548-A926-4F319BF90882Q35232840-CD3DC6A9-8633-4DE1-9F12-3382D45840CDQ35278136-592E834D-AF8E-461A-8EC3-59D48F392265Q35563902-A8B94EC2-2C20-4705-B069-2599EF46041AQ35856215-F5080C70-298A-4AC3-9EB0-8BC11EBB28F5Q35892721-5F5817FF-2851-44FC-A47E-2EEC70F79443Q36127128-CEF167A1-5766-4DF7-8711-3FB5524C71F1Q36588875-55440916-4828-4B99-920B-D7A644A94737Q36868895-DC3FE8EE-2774-4FE8-B3F9-3FF3C251EC81Q37093673-0A26FD92-91F6-4AC3-86D4-78B26975500FQ37136339-0540FA1D-FC2A-4559-AC91-4843AD739D20Q37502782-B84769DB-3C63-42F1-9A36-2109A28CE57AQ37553888-7C1848F8-A2D1-487E-9FBC-2E0F7998EAA8Q37602717-200C33A7-2FE0-445E-88CA-97C0B46DC3DFQ37634712-E5F8A9AC-12A3-473A-8EB5-6320750E0E5CQ37641627-69E824AD-2AA1-4202-95EE-AFEAB0E042A5Q37675522-8B9021CB-58AF-4452-8251-52FB2A42EE26Q37680225-D51548CF-5E07-4B10-9311-3DD4E7160A3EQ38370778-CE11B715-C27E-4742-AA02-AF6608A1FE47Q38639717-81E60165-0347-474C-A0CD-6D2A5B8716DAQ38727148-9D771464-EF62-43DF-88CD-9B0AFA5448CCQ38854108-7F2510FC-8B3F-43F1-9122-3F61AAF148A0Q38891681-02CD0F9A-2B03-4AAA-915E-9B194D0468BBQ39117099-9CE60B4C-9EC0-4F33-96EB-94D90BE23123
P2860
Targeting the Fas/FasL signaling pathway in cancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting the Fas/FasL signaling pathway in cancer therapy.
@en
Targeting the Fas/FasL signaling pathway in cancer therapy.
@nl
type
label
Targeting the Fas/FasL signaling pathway in cancer therapy.
@en
Targeting the Fas/FasL signaling pathway in cancer therapy.
@nl
prefLabel
Targeting the Fas/FasL signaling pathway in cancer therapy.
@en
Targeting the Fas/FasL signaling pathway in cancer therapy.
@nl
P2860
P1476
Targeting the Fas/FasL signaling pathway in cancer therapy
@en
P2093
José Fernández-Piqueras
P2860
P304
P356
10.1517/14728222.2011.628937
P407
P577
2012-01-12T00:00:00Z